Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02863107 · ClinicalTrials.gov registry record
Young-Onset Colorectal Cancer
A clinical trial of Colorectal Carcinoma and Rectal Adenocarcinoma, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 818
- Enrollment target
- 5
- Study locations
NCT02863107 is a study of Colorectal Carcinoma and Rectal Adenocarcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 818 participants, below the 1,081-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (24% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT02863107, a study of Colorectal Carcinoma and Rectal Adenocarcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 818 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study investigates the genetic factors that may influence the risk of developing colorectal cancer at a young age. Finding genetic markers for colorectal may help identify patients who are at risk of colorectal cancer. Studying individuals and families at high risk of cancer may help identify cancer genes and other persons at risk.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
Study Locations (5)
Texas
- MD Anderson in The Woodlands - Conroe
- M D Anderson Cancer Center - Houston
- MD Anderson West Houston - Houston
- MD Anderson League City - League City
- MD Anderson in Sugar Land - Sugar Land
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 818 participants |
| Start Date | 2012-06-07 |
| Est. Completion | 2030-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02863107
The ClinicalTrials.gov registry entry for NCT02863107 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 818 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,081-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (24% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Colorectal Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT02863107 reports 5 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02863107 about?
NCT02863107 is a clinical study titled "Young-Onset Colorectal Cancer". This study investigates the genetic factors that may influence the risk of developing colorectal cancer at a young age. Finding genetic markers for colorectal may help identify patients who are at risk of colorectal cancer. Studying individuals and families at high risk of cancer may help identify c...
What is the current status of trial NCT02863107?
This trial is currently active not recruiting. The enrollment target is 818 participants. The study started on 2012-06-07. Estimated completion is 2030-08-31.
What conditions does trial NCT02863107 study?
This clinical trial studies the following conditions: Colorectal Carcinoma, Rectal Adenocarcinoma, Colon Adenocarcinoma.
What interventions are being tested in trial NCT02863107?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT02863107?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02863107 being conducted?
This trial has 5 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RECRUITING · Phase 1
-
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RECRUITING · NA
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
RECRUITING · Phase 1
-
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.